Aignostics

Aignostics develops explainable AI models that analyze complex multimodal biomedical data—including histopathology images—to support precision medicine. Their foundation models set new industry standards in performance on public benchmarks. The technology enables accurate tumor microenvironment profiling, biomarker discovery, translational research support, companion diagnostic development (CDx), and digital pathology solutions for biopharma clients. Recent collaborations with Mayo Clinic have produced state-of-the-art foundation models rapidly using millions of diverse slide images. The company’s offerings are used by leading pharma companies globally to accelerate drug development pipelines with scalable digital pathology analytics.